Figure 1From: Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapyModel for origin of nasopharyngeal carcinoma stem or stem-like cells. BL, B lymphocytes; CSC, cancer stem-like cell; EBV, Epstein–Barr virus; EMT, epithelial–mesenchymal transition; MET, mesenchymal–epithelial transition; NE, nasopharyngeal epithelial cells; NPC, nasopharyngeal carcinoma; NSC, normal stem cell; TIC, tumor-initiating cell.Back to article page